誉衡药业
(002437)
| 流通市值：61.36亿 | | | 总市值：65.58亿 |
| 流通股本：21.01亿 | | | 总股本：22.46亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 461,761,822.17 | 481,962,600.35 | 468,713,400.56 | 433,920,872.38 |
| 应收票据及应收账款 | 107,759,215.78 | 126,128,838.13 | 163,476,719.81 | 198,413,991.14 |
| 其中：应收票据 | 764,616.06 | 1,245,321.46 | 2,556,237.62 | 467,224.14 |
| 应收账款 | 106,994,599.72 | 124,883,516.67 | 160,920,482.19 | 197,946,767 |
| 应收款项融资 | 4,216,130.28 | 2,496,094.2 | 2,412,478 | 3,826,804.6 |
| 预付款项 | 17,468,226.78 | 14,269,451.4 | 18,976,384.96 | 18,973,521.07 |
| 其他应收款合计 | 19,462,098.86 | 18,869,579.34 | 20,530,307.76 | 23,946,081.63 |
| 存货 | 185,855,538.43 | 188,671,540.43 | 187,622,761.59 | 185,347,885.46 |
| 其他流动资产 | 9,830,208.86 | 14,794,268.45 | 8,694,959.28 | 9,706,482.64 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 946,591,300.71 | 877,194,205.18 | 870,427,011.96 | 874,135,638.92 |
| 非流动资产: | | | | |
| 长期股权投资 | 68,143,581.25 | 68,292,921.95 | 69,029,790.03 | 69,069,893.23 |
| 其他权益工具投资 | 78,970,365.7 | 78,970,365.7 | 78,970,365.7 | 78,970,365.7 |
| 其他非流动金融资产 | 133,398,650.69 | 130,295,554.02 | 140,447,258.27 | 139,292,638.13 |
| 投资性房地产 | 34,177,814.69 | 34,504,614.15 | 31,579,101.21 | 31,877,295.9 |
| 固定资产 | 1,011,787,724.41 | 1,023,742,769.78 | 1,028,050,473.9 | 1,029,478,059.09 |
| 在建工程 | 1,821,098.38 | 1,885,323.06 | 4,937,476.69 | 6,030,779.25 |
| 使用权资产 | 3,054,835.59 | 3,394,261.77 | 3,733,687.95 | - |
| 无形资产 | 189,136,745.29 | 166,661,527.72 | 168,839,597.13 | 176,400,250.01 |
| 开发支出 | 14,847,715.68 | 14,447,307.96 | 13,286,626.23 | 12,101,382.24 |
| 商誉 | 369,032,276.3 | 369,032,276.3 | 369,032,276.3 | 369,032,276.3 |
| 递延所得税资产 | 16,098,192.84 | 16,464,177.76 | 19,061,615.56 | 19,380,782.7 |
| 其他非流动资产 | 11,590,698.91 | 40,227,307.29 | 29,683,713.45 | 34,403,802.27 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,932,059,699.73 | 1,947,918,407.46 | 1,956,651,982.42 | 1,966,037,524.82 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,878,651,000.44 | 2,825,112,612.64 | 2,827,078,994.38 | 2,840,173,163.74 |
| 流动负债: | | | | |
| 短期借款 | 70,041,708.33 | - | 35,031,388.89 | 80,036,055.55 |
| 应付票据及应付账款 | 64,307,822.85 | 60,446,225.62 | 59,264,071.8 | 66,551,726.11 |
| 应付账款 | 64,307,822.85 | 60,446,225.62 | 59,264,071.8 | 66,551,726.11 |
| 合同负债 | 36,128,094.47 | 44,195,283.87 | 36,576,813.67 | 49,796,899.56 |
| 应付职工薪酬 | 62,794,456.33 | 66,821,715.9 | 90,544,508.95 | 75,415,083.16 |
| 应交税费 | 28,601,686.29 | 32,289,107.21 | 32,505,982.93 | 33,283,824.04 |
| 其他应付款合计 | 615,780,995.52 | 604,127,753.9 | 611,940,227.88 | 523,808,828.27 |
| 应付股利 | 1,226,505.38 | 1,226,505.38 | 1,226,505.38 | 1,226,505.38 |
| 一年内到期的非流动负债 | 1,345,712.18 | 1,334,338.14 | 1,000,666.67 | 2,502,694.43 |
| 其他流动负债 | 12,910,827.87 | 13,819,155.29 | 4,989,319.32 | 6,334,546.94 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 891,911,303.84 | 823,033,579.93 | 871,852,980.11 | 837,729,658.06 |
| 非流动负债: | | | | |
| 长期借款 | - | - | 8,505,666.67 | 32,534,944.44 |
| 租赁负债 | 1,534,385.86 | 1,946,812.1 | 3,678,812.72 | - |
| 递延收益 | 12,680,952.29 | 12,918,087.74 | 16,805,223.19 | 17,042,358.64 |
| 递延所得税负债 | 13,152,705.37 | 13,283,852.93 | 11,698,491.99 | 11,832,822.59 |
| 其他非流动负债 | 1,078,000 | 1,078,000 | - | - |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 28,446,043.52 | 29,226,752.77 | 40,688,194.57 | 61,410,125.67 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 920,357,347.36 | 852,260,332.7 | 912,541,174.68 | 899,139,783.73 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 2,247,442,726 | 2,279,749,950 | 2,280,693,950 | 2,270,513,950 |
| 资本公积 | 412,672,398.11 | 456,814,859.42 | 450,408,698.52 | 443,332,821.92 |
| 减:库存股 | 102,033,750 | 102,033,750 | 103,213,750 | - |
| 其他综合收益 | -7,253,928.75 | -7,213,402.58 | -8,078,702.28 | -7,464,975.59 |
| 专项储备 | 4,127,197.38 | 4,127,197.38 | 4,127,197.38 | 4,127,415.38 |
| 未分配利润 | -620,495,299.41 | -680,747,566.67 | -730,021,261.38 | -788,536,257.25 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,934,459,343.33 | 1,950,697,287.55 | 1,893,916,132.24 | 1,921,972,954.46 |
| 少数股东权益 | 23,834,309.75 | 22,154,992.39 | 20,621,687.46 | 19,060,425.55 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,958,293,653.08 | 1,972,852,279.94 | 1,914,537,819.7 | 1,941,033,380.01 |
| 负债和股东权益合计 | 2,878,651,000.44 | 2,825,112,612.64 | 2,827,078,994.38 | 2,840,173,163.74 |
| 公告日期 | 2025-04-26 | 2025-04-26 | 2024-10-29 | 2024-08-24 |
| 审计意见(境内) | | 标准无保留意见 | | |